NEUBERGER BERMAN GROUP LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1465109
NEW YORK, NY
Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$330,016,949
+$4,189,783 QoQ
Shares Held
427,129
+1.2% QoQ
Ownership
0.407%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 97.04187035268116.ToString("F0")%
Shared 0.ToString("F0")%
None 2.9581296473188363.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEUBERGER BERMAN GROUP LLC holds $1,136,881,142 across 81 Biotechnology names. REGN ranks #1 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
427,129 | $330,016,949 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,522 | $246,276,633 | |
| 3 | TECH |
BIO-TECHNE Corp
|
3,340,837 | $174,592,141 | |
| 4 | CAI |
Caris Life Sciences, Inc.
|
3,590,586 | $64,199,677 | |
| 5 | INSM |
INSMED Inc
|
270,700 | $44,264,863 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
443,272 | $33,285,294 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,496 | $30,935,021 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
480,740 | $25,344,612 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $330,016,949 | 427,129 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $325,827,166 | 422,127 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $233,743,509 | 415,714 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $212,726,850 | 405,194 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $276,846,468 | 436,508 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $329,473,282 | 462,529 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $472,626,990 | 449,590 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $479,059,473 | 455,800 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $434,741,332 | 451,684 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $409,185,649 | 465,889 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $582,500,139 | 707,811 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $509,202,711 | 708,663 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $566,031,207 | 688,879 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $468,715,978 | 649,650 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $407,286,809 | 591,239 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $379,150,190 | 641,399 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $416,624,291 | 596,524 | Shares | Defined | 2022-05-23 | |
| 2021-12-31 | $378,805,904 | 599,832 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $338,657,517 | 559,598 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $410,014,159 | 734,082 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $357,594,006 | 755,789 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $273,227,208 | 565,559 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $297,950,741 | 532,264 | Shares | Defined | 2020-11-12 | |
| 2020-03-31 | $240,600,990 | 492,742 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||